Skip to main content

Table 1 General description of the amikacin products studied

From: Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model

Amikacin product

Form

Demonstrated pharmaceutical equivalencea

Batch

Manufacturer

Distributor

BMS (innovator)

1 g in 4 ml

Not applicable

99A106

Grove, Ecuador

The manufacturer

0.5 g in 2 ml

00G030

05H091A

Bristol-Myers Squibb, Ecuador

Carlon

0.5 g in 2 ml

Yes

111V0203

Carlon, Colombia

The manufacturer

FormasG

0.5 g in 2 ml

No

02525

Vitropharma, Colombia

Formas genericas farmaceuticas, Colombia

Gencol

0.25 g in 2 ml

Yes

0100

0200

Chalver, Colombia

The manufacturer

Genven

0.5 g in 2 ml

No

904037

Leti for Genven, Venezuela

The manufacturer

Pisa

0.5 g in 2 ml

Yes

060865

011306

PiSa, Mexico

ECAR, Colombia

Quimicol

0.5 g in 2 ml

No

3780199

Quimicol, Colombia

The manufacturer

Scalpi

0.5 g in 2 ml

Yes

AK030072

Farmionni-Lubelca, Colombia

Farmionni scalpi, Colombia

Serpharma

0.25 g in 2 ml

No

AK020086

Farmionni-Lubelca, Colombia

Serpharma, Colombia

0.1 g in 2 ml

AK010172

Sigma (reference)

1 g powder

Yes

120K1643

Sigma Chemical Co, USA

The manufacturer

Zokumey

0.25 g in 2 ml

No

AK020035

Farmionni-Lubelca, Colombia

Zokumey pharma, Colombia

  1. aThe pharmaceutical equivalence (same potency and concentration of the active ingredient) tested by microbiological assay was published elsewhere [8]